Carotid Revascularization in the Era of Modern Medical Therapy: Is Urgency Still Justified?

Calvin D. De Louche, Alun H. Davies · 2026

Read Carotid Revascularization in the Era of Modern Medical Therapy: Is Urgency Still Justified? by Calvin D. De Louche, Alun H. Davies (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13549611.txt.

Description

A peer-reviewed research article from Europe PMC (2026). (CEA) can often be planned and delivered selectively, and that OMT alone may be reasonable for some lower-risk groups until trial evidence matures. The timing calculus may differ for transfemoral carotid artery stenting (TF-CAS) and transcarotid artery revascularization (TCAR) because of different antiplatelet requirements and procedural risk profiles, but the central principle remains the same: treat medically now, then revascularize selectively when residual risk justifies it.

Catalog record

CREATORCalvin D. De Louche, Alun H. Davies
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE21 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13549611

Browse the full library · About the Tower of Babel